Exponent, Inc.
NASDAQ:EXPOConsulting Services
-$0.25 today
- Market cap
- $4.24B
- Beta
- 0.73
- P/E (TTM)
- 25.9
- EPS (TTM)
- $2.19
- Dividend yield
- 2.15%
Volume 0.44M
Average 0.60M
EXPO Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Exponent, Inc.NASDAQ: EXPO
Accumulated OCI · Q3 FY2026 · quarter ended Oct 2026
Accumulated OCI remains negative
Q3 FY2026 Accumulated OCI was -$2.5M, compared with -$2.4M a year earlier.
Context
- Accumulated OCI amounted to 0.5% of total assets at the end of Q3 FY2026, up 0.2 pp from a year earlier.
- Accumulated OCI grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -3.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (2.29M) USD
- Year-over-year change
- +39.6%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-02 | (2.29M) | +39.6% |
| FY2024 | 2025-01-03 | (3.79M) | -27.3% |
| FY2023 | 2023-12-29 | (2.98M) | +17.0% |
| FY2022 | 2022-12-30 | (3.59M) | -80.9% |
| FY2021 | 2021-12-31 | (1.98M) | — |
Accumulated OCI vs competitors
How EXPO compares with its peers on the latest reported figures
- EXPO's Oct 2026 Accumulated OCI of -$2.5M is the 3rd highest of the 11 companies compared; the peer median is -$12.84M.
- Its year-over-year change of -3.9% is the 8th highest of 11, against a peer median of +1.2%.
- Accumulated OCI amounts to 0.5% of total assets for EXPO, versus a peer median of 1.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LGNLegence Corp. Class A Common stock | Sep 2026 | $7.79M | +3241.9% | — | 0.2% |
| Apr 2026 | -$151K | +69.7% | — | 0.0% | |
| Oct 2026 | -$2.5M | -3.9% | — | 0.5% | |
| Apr 2026 | -$10.8M | +18.9% | — | 1.6% | |
| Jun 2026 | -$11.13M | -45.3% | — | 0.7% | |
| Sep 2026 | -$11.59M | -54.6% | — | 0.7% | |
| Mar 2026 | -$14.1M | +23.6% | — | 0.7% | |
| Sep 2026 | -$96.44M | -0.7% | — | 2.2% | |
| Jun 2026 | -$139.86M | -9.1% | — | 4.0% | |
| Sep 2026 | -$274M | +3.2% | — | 3.8% | |
| Oct 2026 | -$931M | -3.9% | — | 13.3% | |
| Peer median (excluding EXPO) | -$12.84M | +1.2% | — | 1.2% | |
Competitors are the stored peer set for EXPO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Jan 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 297.69M | 161.46M | 187.15M | 258.9M | 221.93M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 139.86M | 170.11M | 167.36M | 161.41M | 181.51M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 17.59M | 25.02M | 26.57M | 24.14M |
| Total Current Assets | 452.76M | 349.16M | 379.53M | 446.88M | 427.58M |
| Property, Plant & Equipment (Net) | 74.34M | 83.55M | 99.92M | 148.26M | 145.36M |
| Goodwill | 8.61M | 8.61M | 8.61M | 8.61M | 8.61M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 46.55M | 53.91M | 53.82M | 57.13M | 98.17M |
| Other Non-current Assets | 101.48M | 91.44M | 104.9M | 116.4M | 128.9M |
| Total Non-current Assets | 230.98M | 237.51M | 267.25M | 330.39M | 381.04M |
| Total Assets | 683.74M | 586.66M | 646.78M | 777.27M | 808.62M |
| Account Payables | 3.19M | 8.64M | 4.49M | 5.27M | 6.87M |
| Short-term Debt | 0 | 0 | 0 | 0 | 6.89M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 19.76M | 18.83M | 21.71M | 16.37M | 18.87M |
| Other Current Liabilities | 9.38M | 10.17M | 13.17M | 14.98M | 24.07M |
| Total Current Liabilities | 152.98M | 159.03M | 161.91M | 163.18M | 178M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 31.1M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 103.89M | 93.54M | 106.82M | 116.94M | 133.23M |
| Total Non-current Liabilities | 113.69M | 106.88M | 128.78M | 193.02M | 240.27M |
| Total Liabilities | 266.67M | 265.91M | 290.69M | 356.2M | 418.27M |
| Common Stock | 66K | 66K | 66K | 66K | 66K |
| Retained Earnings | 478.37M | 528.81M | 574.08M | 624.15M | 668.42M |
| Accumulated OCI | (1.98M) | (3.59M) | (2.98M) | (3.79M) | (2.29M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 417.07M | 320.75M | 356.09M | 421.07M | 390.34M |
| Total Debt | 14.97M | 18.6M | 28.26M | 81.48M | 82.83M |
| Net Debt | (282.72M) | (142.86M) | (158.89M) | (177.42M) | (139.1M) |
Exponent, Inc.
NASDAQ:EXPO
Intrinsic Alpha fair value
Locked
Current Price
$89.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.